8 January, 2019

A new refinement increases the safety of CAR-T therapy

Source: Immedicohospitalario.es Bellicum Pharma has reported the preliminary results of its phase I / II dose escalation study in 12 patients with metastatic pancreatic cancer treated […]
26 December, 2018

Investigations of the Carlos III National Center for Cardiovascular Research

Source: Immedicohospitalario.es The studies published by the CNIC scientists during the year 2017 consolidate this center as an institution of Spanish and international research excellence, highlighting […]
20 December, 2018

New method for the prediction of response to treatment in clinical trials

Source: immedicohospitalario.es Researchers from the universities of Vienna and Lancaster have developed a method aimed at improving precision medicine already during the clinical development phase of […]
14 December, 2018

Combining metformin and an antihypertensive is effective against tumors

Source: redaccionmedica.com A common medication for diabetes, combined with a drug against high blood pressure, is able to inhibit the growth of tumorese induce the death […]
12 December, 2018

Advances in therapies directed to lymphocytes in systemic lupus erythematosus

Source: immedicohospitalario.es Systemic lupus erythematosus (SLE) is an autoimmune disease with multifaceted and extremely variable clinical manifestations, characterized by relapses and outbreaks followed by periods of […]
4 December, 2018

More than 130,000 patients participate in 3,000 clinical trials in Spain

Source: Laverdad.es Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic […]
29 November, 2018

Farma-Biotech promotes nine projects on innovative drugs

Source: redaccionmedica.com Different Spanish biotechnology companies and research groups presented on Wednesday a total of nine advanced innovative drug development projects to representatives of 17 national […]
22 November, 2018

INCLIVA shows the possible improvement of atherosclerosis through a molecule

Source: actasanitaria.com Researchers from the Health Research Institute of the Hospital Clínico de Valencia (INCLIVA) have shown that a molecule used to treat cancer, called PD033299, […]
20 November, 2018

Novartis works with 50 molecules in the development of new CART therapies

Source: redaccionmedica.com The great results obtained with CAR-T therapies in cancer patients in whom chemotherapy has failed have focused the day ‘Towards a greater knowledge of […]
16 November, 2018

Astra Zeneca presents new indications on the benefits of Brilique

Source: redaccionmedica.com AstraZeneca has presented new analyzes of the Pegasus-Timi 54 trial in the framework of the Scientific Conferences of the American Heart Association. These findings […]
15 November, 2018

EMA publishes a report on the impact of Brexit on the authorization of medicines

Source: actasanitaria.com A day after knowing the draft agreement on Brexit that last Tuesday, November 13, reached the European Union (EU) and the British Government, the […]
8 November, 2018

Europe approves a new indication for Xtandi, from Astellas, for prostate cancer

Source: actasanitaria.com The European Commission has approved a new indication of enzalutamide, a drug whose trade name is Xtandi and which was registered by the pharmaceutical […]
Private zoneHoja de Validación
Reembolso de Gastos